VI
Versor Investments’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,400
| Closed | -$18.4K | – | 928 |
|
|
2024
Q2 | $18.4K | Sell |
13,400
-16,379
| -55% | -$22.4K | ﹤0.01% | 699 |
|
|
2024
Q1 | $112K | Sell |
29,779
-35,412
| -54% | -$133K | 0.02% | 649 |
|
|
2023
Q4 | $640K | Buy |
65,191
+8,723
| +15% | +$85.6K | 0.13% | 255 |
|
|
2023
Q3 | $472K | Buy |
+56,468
| New | +$472K | 0.1% | 334 |
|
|
2022
Q3 | – | Sell |
-10,000
| Closed | -$44K | – | 906 |
|
|
2022
Q2 | $44K | Buy |
+10,000
| New | +$44K | ﹤0.01% | 777 |
|
|
2020
Q1 | – | Sell |
-3,148,691
| Closed | -$16.2M | – | 321 |
|
|
2019
Q4 | $16.2M | Sell |
3,148,691
-2,223,929
| -41% | -$11.4M | 0.82% | 27 |
|
|
2019
Q3 | $27.7M | Buy |
5,372,620
+989,998
| +23% | +$5.11M | 1.89% | 16 |
|
|
2019
Q2 | $26.5M | Buy |
4,382,622
+1,264,990
| +41% | +$7.65M | 1.77% | 21 |
|
|
2019
Q1 | $22.5M | Buy |
3,117,632
+2,103,200
| +207% | +$15.2M | 2.14% | 20 |
|
|
2018
Q4 | $7.51M | Buy |
+1,014,432
| New | +$7.51M | 1.72% | 16 |
|